HIV self-testing and long-acting injections for minibus drivers
Part of Infections clinical trials.
This trial tests a program that gives HIV self-test kits and offers long-acting injectable medications to help prevent HIV among commercial minibus drivers in Nigeria. It aims to make HIV testing and prevention easy and private for drivers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male commercial minibus driver
- You have been driving for at least 6 months
- You are 18 years old or older
- You live in one of the study areas (LGAs) and plan to stay there for the next 12 months
- You own a mobile phone (cell phone)
- You do not have HIV (you have not been told by a doctor that you have HIV)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a support program to help young men who have sex with men and transgender women, who are living with HIV, stay engaged in their care and achieve viral suppression (an undetectable HIV viral load). The program may include extra counseling or reminders to help keep your HIV treatment on track.
This study tests whether medical drones can safely deliver HIV medications and lab samples in remote areas. If successful, it could help people living with HIV get their medicine faster and more reliably.
This study tests different ways to take HIV prevention medicine (PrEP) for men who travel for work. It compares daily pills, pills taken only around sex, and a long-acting injection to see which works best for mobile men in sub-Saharan Africa.
This study tests whether giving at-home HIV and syphilis self-test kits to men who have sex with men (MSM) can help more people learn their status and get linked to care. It also looks at how sharing test results with partners might increase testing and prevent the spread of infections.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.